Francisco, Baby Boy .
HRN: 27-78-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/18/2025
09/25/2025
IV
35mg
Q24
PSNB (PROM X 2days)
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes